Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,260 | 3,005 | 3,945 | 4,041 | 5,149 |
| Operating Income | -3,260 | -3,005 | -3,945 | -4,041 | -5,149 |
| Other Income | 82 | 5 | 79 | 180 | 118 |
| Pre-tax Income | -3,178 | -3,000 | -3,866 | -3,861 | -5,031 |
| Net Income Continuous | -3,178 | -3,000 | -3,866 | -3,861 | -5,031 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -17 |
| Net Income | $-3,178 | $-3,000 | $-3,866 | $-3,861 | $-5,048 |
| EPS Basic Total Ops | -2.41 | -2.87 | -3.71 | -3.70 | -4.55 |
| EPS Basic Continuous Ops | -2.40 | -2.87 | -3.71 | -3.71 | -4.42 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.04 |
| EPS Diluted Total Ops | -2.41 | -2.87 | -3.71 | -3.70 | -4.55 |
| EPS Diluted Continuous Ops | -2.40 | -2.87 | -3.71 | -3.71 | -4.42 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.04 |
| EPS Diluted Before Non-Recurring Items | -2.41 | -2.87 | -3.71 | N/A | N/A |
| EBITDA(a) | $-3,097 | $-2,842 | $-3,783 | $-3,879 | $-4,987 |